Semaglutide reduces appetite by activating GLP-1 receptors in the brain, helping patients lose an average of 1522% of body weight over 68 weeks according to clinical trials
Of all the new companies requesting LegitScript certification in 2024, Roth says over 60 percent offer weight-loss drugs, and 98 percent of those companies offer compounded GLP-1 medications
The SURMOUNT-5 trial provides definitive evidence that Tirzepatide's dual GIP/GLP-1 receptor agonist mechanism translates into superior weight loss efficacy compared to a selective GLP-1 RA, even at its highest approved dose for obesity
Bring your medical documentation
The Science Behind Glutathione Glutathione is a tripeptide (a molecule made of three amino acids: cysteine, glycine, and glutamine) produced naturally in the liver
DURATION-5: exenatide once weekly resulted in greater improvements in glycemic control compared with exenatide twice daily in patients with type 2 diabetes